KUALA LUMPUR (Nov 21): CCM DUOPHARMA BIOTECH BHD []’s earnings dipped 1.3% to RM7.52 million in the third quarter ended Sept 30 from RM7.62 million a year ago due to slightly higher administration expenses.
In its announcement on Monday, the administration expenses increased to RM3.35 million from RM2.40 million a year ago.
However, its revenue increased 6.7% to RM36.76 million from RM34.46 million while earnings per share 5.42 sen compared with 5.49 sen.
For the nine-month period, its earnings rose 1.6% to RM20.37 million from RM20.05 million while its revenue increased at a stronger pace of 5.9% to RM105.09 million from RM99.24 million.
“The increase in revenue was mainly due to increase sales to government hospitals,” it said.
In its announcement on Monday, the administration expenses increased to RM3.35 million from RM2.40 million a year ago.
However, its revenue increased 6.7% to RM36.76 million from RM34.46 million while earnings per share 5.42 sen compared with 5.49 sen.
For the nine-month period, its earnings rose 1.6% to RM20.37 million from RM20.05 million while its revenue increased at a stronger pace of 5.9% to RM105.09 million from RM99.24 million.
“The increase in revenue was mainly due to increase sales to government hospitals,” it said.
